FDA's Overreach on Compounded Peptides Is BPC 157 Banned? Oral vs. Injectable Forms Explained Peptide BPC 157 Does It Work? Breaking Down the Evidence and the Hype The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York FDA mulls compounding for peptides previously flagged over safety risks BioSpace Q&A: Should you trust trending peptide injections?